Bienville Capital Management’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-666
Closed -$5.33K 104
2023
Q3
$5.33K Sell
666
-167
-20% -$992 ﹤0.01% 91
2023
Q2
$3.54K Hold
833
﹤0.01% 89
2023
Q1
$4.69K Hold
833
﹤0.01% 99
2022
Q4
$6.92K Hold
833
﹤0.01% 90
2022
Q3
$27K Sell
833
-416
-33% -$15.4K 0.01% 107
2022
Q2
$50K Buy
+1,249
New +$91.2K 0.02% 131

Other funds holding SNCE

Bienville Capital Management's SNCE Position: Q4 2023 in Review

Bienville Capital Management sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q4 2023, closing a stake of 666 shares — an estimated $5.33K sold.

Bienville Capital Management first reported a position in SNCE in Q2 2022 and held it in 6 quarters. The position peaked at $50K in Q2 2022. 29 funds tracked by Wall St. Rank hold SNCE as of Q4 2023.

  • Bienville Capital Management reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bienville Capital Management sold 666 Science 37 Holdings, Inc. Common Stock shares in Q4 2023, an estimated $5.33K.
  • Bienville Capital Management first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Bienville Capital Management's Science 37 Holdings, Inc. Common Stock position peaked at $50K in Q2 2022.
  • 29 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q4 2023.

Based on Bienville Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.